Literature DB >> 19820205

Pain in youths with neuromuscular disease.

Joyce M Engel1, Deborah Kartin, Gregory T Carter, Mark P Jensen, Kenneth M Jaffe.   

Abstract

To examine the prevalence and characteristics of pain in children with neuromuscular disease (NMD), 42 youths with NMD underwent a comprehensive evaluation including a detailed intake interview and structured questionnaire that included demographic and functional data. Youths who reported chronic pain were further queried about pain characteristics, locations, and intensity using an 11-point numerical rating scale and a modified Brief Pain Inventory (BPI). The sample consisted of 24 males (57%) and 18 females (43%), ages ranging from 9 to 20 years (M = 14.8, SD = 2.96). Participants included 14 (37%) with Duchenne muscular dystrophy, 6 (14%) with myotonic dystrophy, 2 (5%) with Becker dystrophy, 2 (5%) with limb-girdle dystrophy, 2 (5%) with congenital muscular dystrophy, 1 (2%) facioscapulohumeral, and 15 (36%) were classified as ''other NMD.'' Twenty-one (50%) were ambulatory; 26 (62%) used power wheelchairs/scooters, 9 (2%) used manual wheelchairs, 3 (.07%) used crutches/canes, and 1 (2%) used a walker. A total of 23 (55%) of the youths reported having chronic pain. Current pain intensity was 1.30 (range = 0-6), mean pain intensity over the past week was 2.39 (range = 0-7), mean pain duration was 8.75 hours (SD = 12.84). Pain in the legs was most commonly reported and 83% reported using pain medications. This study indicates that chronic pain is a significant problem in youths with NMD. These data strongly support making comprehensive pain assessment and management an integral part of the standard of care for youths with NMD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19820205      PMCID: PMC3028598          DOI: 10.1177/1049909109346165

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  58 in total

1.  Profiles of neuromuscular diseases. Becker's muscular dystrophy.

Authors:  C M McDonald; R T Abresch; G T Carter; W M Fowler; E R Johnson; D D Kilmer
Journal:  Am J Phys Med Rehabil       Date:  1995 Sep-Oct       Impact factor: 2.159

2.  Phrenic nerve involvement in Charcot-Marie-Tooth.

Authors:  G T Carter
Journal:  Muscle Nerve       Date:  1995-10       Impact factor: 3.217

3.  Evaluation of phrenic nerve and pulmonary function in hereditary motor and sensory neuropathy, type I.

Authors:  G T Carter; D D Kilmer; H W Bonekat; J S Lieberman; W M Fowler
Journal:  Muscle Nerve       Date:  1992-04       Impact factor: 3.217

4.  Profiles of neuromuscular diseases. Duchenne muscular dystrophy.

Authors:  C M McDonald; R T Abresch; G T Carter; W M Fowler; E R Johnson; D D Kilmer; B J Sigford
Journal:  Am J Phys Med Rehabil       Date:  1995 Sep-Oct       Impact factor: 2.159

5.  Profiles of neuromuscular diseases. Hereditary motor and sensory neuropathy, types I and II.

Authors:  G T Carter; R T Abresch; W M Fowler; E R Johnson; D D Kilmer; C M McDonald
Journal:  Am J Phys Med Rehabil       Date:  1995 Sep-Oct       Impact factor: 2.159

6.  Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy.

Authors:  D D Kilmer; R T Abresch; M A McCrory; G T Carter; W M Fowler; E R Johnson; C M McDonald
Journal:  Am J Phys Med Rehabil       Date:  1995 Sep-Oct       Impact factor: 2.159

7.  Profiles of neuromuscular diseases. Spinal muscular atrophy.

Authors:  G T Carter; R T Abresch; W M Fowler; E R Johnson; D D Kilmer; C M McDonald
Journal:  Am J Phys Med Rehabil       Date:  1995 Sep-Oct       Impact factor: 2.159

8.  Profiles of neuromuscular diseases. Myotonic dystrophy.

Authors:  E R Johnson; R T Abresch; G T Carter; D D Kilmer; W M Fowler; B J Sigford; R L Wanlass
Journal:  Am J Phys Med Rehabil       Date:  1995 Sep-Oct       Impact factor: 2.159

9.  Profiles of neuromuscular diseases. Limb-girdle syndromes.

Authors:  C M McDonald; E R Johnson; R T Abresch; G T Carter; W M Fowler; D D Kilmer
Journal:  Am J Phys Med Rehabil       Date:  1995 Sep-Oct       Impact factor: 2.159

10.  Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy.

Authors:  Jordi Miró; Katherine A Raichle; Gregory T Carter; Sarah A O'Brien; Richard T Abresch; Craig M McDonald; Mark P Jensen
Journal:  Am J Hosp Palliat Care       Date:  2009-05-04       Impact factor: 2.500

View more
  34 in total

1.  Patterns of decline in upper limb function of boys and men with DMD: an international survey.

Authors:  Mariska M H P Janssen; Arjen Bergsma; Alexander C H Geurts; Imelda J M de Groot
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

2.  Validity of three rating scales for measuring pain intensity in youths with physical disabilities.

Authors:  J Miró; E Castarlenas; R de la Vega; E Solé; C Tomé-Pires; M P Jensen; J M Engel; M Racine
Journal:  Eur J Pain       Date:  2015-03-31       Impact factor: 3.931

3.  The role of perceived family social support and parental solicitous responses in adjustment to bothersome pain in young people with physical disabilities.

Authors:  Jordi Miró; Rocío de la Vega; Kevin J Gertz; Mark P Jensen; Joyce M Engel
Journal:  Disabil Rehabil       Date:  2017-11-12       Impact factor: 3.033

4.  Defining mild, moderate, and severe pain in young people with physical disabilities.

Authors:  Jordi Miró; Rocío de la Vega; Ester Solé; Mélanie Racine; Mark P Jensen; Santiago Gálan; Joyce M Engel
Journal:  Disabil Rehabil       Date:  2016-06-13       Impact factor: 3.033

5.  Consensus statement on standard of care for congenital myopathies.

Authors:  Ching H Wang; James J Dowling; Kathryn North; Mary K Schroth; Thomas Sejersen; Frederic Shapiro; Jonathan Bellini; Hali Weiss; Marc Guillet; Kimberly Amburgey; Susan Apkon; Enrico Bertini; Carsten Bonnemann; Nigel Clarke; Anne M Connolly; Brigitte Estournet-Mathiaud; Dominic Fitzgerald; Julaine M Florence; Richard Gee; Juliana Gurgel-Giannetti; Allan M Glanzman; Brittany Hofmeister; Heinz Jungbluth; Anastassios C Koumbourlis; Nigel G Laing; Marion Main; Leslie A Morrison; Craig Munns; Kristy Rose; Pamela M Schuler; Caroline Sewry; Kari Storhaug; Mariz Vainzof; Nanci Yuan
Journal:  J Child Neurol       Date:  2012-03       Impact factor: 1.987

6.  Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain.

Authors:  Jordi Miró; Kevin J Gertz; Gregory T Carter; Mark P Jensen
Journal:  Muscle Nerve       Date:  2014-06       Impact factor: 3.217

7.  GDNF induces mechanical hyperalgesia in muscle by reducing I(BK) in isolectin B4-positive nociceptors.

Authors:  J Hendrich; P Alvarez; X Chen; J D Levine
Journal:  Neuroscience       Date:  2012-06-13       Impact factor: 3.590

8.  Chronic pain prevalence and associated factors in adolescents with and without physical disabilities.

Authors:  Rocío de la Vega; Cornelius Groenewald; Maggie H Bromberg; Sarah E Beals-Erickson; Tonya M Palermo
Journal:  Dev Med Child Neurol       Date:  2018-02-22       Impact factor: 5.449

9.  Pain catastrophizing in youths with physical disabilities and chronic pain.

Authors:  Joyce M Engel; Sylia Wilson; Susan T Tran; Mark P Jensen; Marcia A Ciol
Journal:  J Pediatr Psychol       Date:  2012-10-01

10.  IB4(+) nociceptors mediate persistent muscle pain induced by GDNF.

Authors:  Pedro Alvarez; Xiaojie Chen; Oliver Bogen; Paul G Green; Jon D Levine
Journal:  J Neurophysiol       Date:  2012-08-22       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.